- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1661-4917
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Immunotherapy in Ovarian Cancer ; volume:70 ; number:1 ; day:9 ; month:8 ; year:2022 ; pages:1-8 ; date:12.2022
Archivum immunologiae et therapiae experimentalis ; 70, Heft 1 (9.8.2022), 1-8, 12.2022
- Urheber
-
Siminiak, Natalia
Czepczyński, Rafał
Zaborowski, Mikołaj Piotr
Iżycki, Dariusz
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s00005-022-00655-8
- URN
-
urn:nbn:de:101:1-2022102700131952376195
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:23 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Siminiak, Natalia
- Czepczyński, Rafał
- Zaborowski, Mikołaj Piotr
- Iżycki, Dariusz
- SpringerLink (Online service)
Ähnliche Objekte (12)
Adoptive immunotherapy against ovarian cancer
Nanotechnology for boosting ovarian cancer immunotherapy
Are antiangiogenics a good ‘partner’ for immunotherapy in ovarian cancer?
Mitophagy genes in ovarian cancer: a comprehensive analysis for improved immunotherapy
Investigating PPT2’s role in ovarian cancer prognosis and immunotherapy outcomes
Immunotherapy that improves response to chemotherapy in high-grade serous ovarian cancer
Artificial Mini Dendritic Cells Boost T Cell–Based Immunotherapy for Ovarian Cancer
An immune-related exosome signature predicts the prognosis and immunotherapy response in ovarian cancer
Nanomedicine Strategies for Heating “Cold” Ovarian Cancer (OC): Next Evolution in Immunotherapy of OC
Ovarian cancer
Ovarian cancer
Integrative multi-omics analysis uncovers tumor-immune-gut axis influencing immunotherapy outcomes in ovarian cancer
Adoptive immunotherapy against ovarian cancer
Nanotechnology for boosting ovarian cancer immunotherapy
Are antiangiogenics a good ‘partner’ for immunotherapy in ovarian cancer?
Mitophagy genes in ovarian cancer: a comprehensive analysis for improved immunotherapy
Investigating PPT2’s role in ovarian cancer prognosis and immunotherapy outcomes
Immunotherapy that improves response to chemotherapy in high-grade serous ovarian cancer
Artificial Mini Dendritic Cells Boost T Cell–Based Immunotherapy for Ovarian Cancer
An immune-related exosome signature predicts the prognosis and immunotherapy response in ovarian cancer
Nanomedicine Strategies for Heating “Cold” Ovarian Cancer (OC): Next Evolution in Immunotherapy of OC
Ovarian cancer
Ovarian cancer
Integrative multi-omics analysis uncovers tumor-immune-gut axis influencing immunotherapy outcomes in ovarian cancer
Adoptive immunotherapy against ovarian cancer
Nanotechnology for boosting ovarian cancer immunotherapy
Are antiangiogenics a good ‘partner’ for immunotherapy in ovarian cancer?
Mitophagy genes in ovarian cancer: a comprehensive analysis for improved immunotherapy
Investigating PPT2’s role in ovarian cancer prognosis and immunotherapy outcomes
Immunotherapy that improves response to chemotherapy in high-grade serous ovarian cancer
Artificial Mini Dendritic Cells Boost T Cell–Based Immunotherapy for Ovarian Cancer
An immune-related exosome signature predicts the prognosis and immunotherapy response in ovarian cancer
Nanomedicine Strategies for Heating “Cold” Ovarian Cancer (OC): Next Evolution in Immunotherapy of OC
Ovarian cancer
Ovarian cancer